Catalyst Wire Dossier Catalyst Wire Dossier

Tocilizumab STADA

tocilizumab · STADA Arzneimittel AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tocilizumab STADA, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: EMA Authorised: Tocilizumab STADA (previously Tofidence) (tocilizumab) — STADA Arzneimittel AG

See pricing